{"id":72492,"date":"2012-03-26T14:55:14","date_gmt":"2012-03-26T14:55:14","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/genetics-of-flu-susceptibility.php"},"modified":"2024-08-17T15:49:37","modified_gmt":"2024-08-17T19:49:37","slug":"genetics-of-flu-susceptibility","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-genetic-engineering\/genetics-of-flu-susceptibility.php","title":{"rendered":"Genetics of flu susceptibility"},"content":{"rendered":"<p><p>Public  release date: 25-Mar-2012  [ |   E-mail   |  Share    ]  <\/p>\n<p>    Contact: Aileen Sheehy    <a href=\"mailto:as22@sanger.ac.uk\">as22@sanger.ac.uk<\/a>    44-122-349-2368    Wellcome Trust Sanger    Institute<\/p>\n<p>    A genetic finding could help explain why influenza becomes a    life-threating disease to some people while it has only mild    effects in others. New research led by the Wellcome Trust    Sanger Institute has identified for the first time a human gene    that influences how we respond to influenza infection.  <\/p>\n<p>    People who carry a particular variant of a gene called IFITM3    are significantly more likely to be hospitalised when they fall    ill with influenza than those who carry other variants, the    team found. This gene plays a critical role in protecting the    body against infection with influenza and a rare version of it    appears to make people more susceptible to severe forms of the    disease. The results are published in the journal    Nature.  <\/p>\n<p>    A central question about viruses is why some people suffer    badly from an infection and others do not. IFITM3 is an    important protein that protects cells against virus infection    and is thought to play a critical role in the immune system's    response against such viruses as H1N1 pandemic influenza,    commonly known as 'swine flu'. When the protein is present in    large quantities, the spread of the virus in lungs is hindered,    but if the protein is defective or absent, the virus can spread    more easily, causing severe disease.  <\/p>\n<p>    \"Although this protein is extremely important in limiting the    spread of viruses in cells, little is known about how it works    in lungs,\" explains Aaron Everitt, first author from the    Wellcome Trust Sanger Institute. \"Our research plays a    fundamental part in explaining how both the gene and protein    are linked to viral susceptibility.\"  <\/p>\n<p>    The antiviral role of IFITM3 in humans was first suggested by    studies using a genetic screen, which showed that the protein    blocked the growth of influenza virus and dengue virus in    cells. This led the team to ask whether IFITM3 protected mice    from viral infections. They removed the IFITM3 gene in mice and    found that once they contracted influenza, the symptoms became    much more severe compared to mice with IFITM3. In effect, they    found the loss of this single gene in mice can turn a mild case    of influenza into a fatal infection.  <\/p>\n<p>    The researchers then sequenced the IFITM3 genes of 53 patients    hospitalised with influenza and found that some have a genetic    mutant form of IFITM3, which is rare in normal people. This    variant gene encodes a shortened version of the protein which    makes cells more susceptible to viral infection.  <\/p>\n<p>    \"Since IFITM3 appears to be a first line defender against    infection, our efforts suggest that individuals and populations    with less IFITM3 activity may be at increased risk during a    pandemic and that IFITM3 could be vital for defending human    populations against other viruses such as avian influenza virus    and dengue virus\" says Dr. Abraham Brass, co-senior author and    Assistant Professor at the Ragon Institute and Gastrointestinal    Unit of Massachusetts General Hospital.  <\/p>\n<p>    This research was a collaboration between institutes in the    United States and the United Kingdom. The samples for this    study were obtained from the MOSAIC consortium in England and    Scotland, co-ordinated from the Centre for Respiratory    Infection (CRI) at Imperial College London, and the GenISIS    consortium in Scotland at the Roslin Institute of the    University of Edinburgh. These were pivotal for the human    genetics component of the work.  <\/p>\n<\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2012-03\/wtsi-gof032112.php\" title=\"Genetics of flu susceptibility\" rel=\"noopener\">Genetics of flu susceptibility<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Public release date: 25-Mar-2012 [ | E-mail | Share ] Contact: Aileen Sheehy <a href=\"mailto:as22@sanger.ac.uk\">as22@sanger.ac.uk<\/a> 44-122-349-2368 Wellcome Trust Sanger Institute A genetic finding could help explain why influenza becomes a life-threating disease to some people while it has only mild effects in others. New research led by the Wellcome Trust Sanger Institute has identified for the first time a human gene that influences how we respond to influenza infection <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-genetic-engineering\/genetics-of-flu-susceptibility.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[388386],"tags":[],"class_list":["post-72492","post","type-post","status-publish","format-standard","hentry","category-human-genetic-engineering"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/72492"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=72492"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/72492\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=72492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=72492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=72492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}